No annual revenue total was found in MOSAIC IMMUNOENGINEERING, INC.'s SEC filings.
Mosaic Immunoengineering, Inc. (CPMV) files with the SEC under industry code 2836, Biological Products, (No Diagnostic Substances).
Revenue
—
Net income (TTM)
$-687,345
+0.8% vs year-ago TTM
Operating cash flow (TTM)
$-53,557
+43.7% vs year-ago TTM
Free cash flow
$-760,766
+13.7% vs prior year
EPS
$-0.10
+23.1% vs prior year
Dividend per share
None
Shares outstanding
7.24M
+0.0% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CPMV (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Huntington Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 836564
- Former names
- PATRIOT SCIENTIFIC CORP (until Nov 19, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$616,119 | -$879,655 | -$1.4M | -$2.6M | — |
| Net income | -$687,846 | -$921,983 | -$1.0M | -$2.4M | -$3.7M |
| Diluted EPS | -$0.10 | -$0.13 | -$0.14 | -$0.33 | -$0.55 |
| Operating cash flow | -$111,397 | -$241,159 | -$497,467 | -$690,129 | -$679,236 |
| Total assets | $19,882 | $141,611 | $179,533 | $261,277 | $269,494 |
| Total liabilities | $7.5M | $6.9M | $6.1M | $5.1M | $3.1M |
| Stockholders' equity | -$7.5M | -$6.8M | -$5.9M | -$4.9M | -$2.8M |
| Cash and investments | $3,622 | $115,019 | $156,178 | $220,645 | $226,142 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 19, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 19, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 20, 2025 | Mar 31, 2025 |
All 553 Mosaic Immunoengineering, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.